Evidence map›Paper›PMID 25229257›Full record

ArticleJAMA psychiatry2014

Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology.

Robert H Pietrzak, Mika Naganawa, Yiyun Huang, Stefani Corsi-Travali, Ming-Qiang Zheng, Murray B Stein, Shannan Henry, Keunpoong Lim, Jim Ropchan, Shu-Fei Lin and 2 more

RetractedErratum issuedOpen access · bronzeAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in JAMA psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. [Comorbidity of posttraumatic stress disorder and addiction from a biopsychosocial perspective].Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Impact of Pharmacological Manipulation of theThe Journal of pharmacology and experimental therapeutics · 2019
    Article
  13. Transdiagnostic psychiatry: a systematic review.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2019
    Article
  14. Article
  15. Review
  16. Article
  17. Brain mechanisms mediating effects of stress on reward sensitivity.Current opinion in behavioral sciences · 2018
    Article
  18. Article
  19. Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  20. Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine.The international journal of neuropsychopharmacology · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Robert H PietrzakUS Department of Veterans Affairs National Center for Posttraumatic Stress Disorder, Clinical Neurosciences Division, VA Connecticut Healthcare System, West Haven.
Mika NaganawaDepartment of Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut.
Yiyun HuangDepartment of Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut.
Stefani Corsi-TravaliDepartment of Psychiatry, New York University School of Medicine, New York.
Ming-Qiang ZhengDepartment of Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut.
Murray B SteinDepartment of Psychiatry, School of Medicine, University of California, San Diego.
Shannan HenryDepartment of Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut.
Keunpoong LimDepartment of Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut.
Jim RopchanDepartment of Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut.
Shu-Fei LinDepartment of Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut.
Richard E CarsonDepartment of Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut.
Alexander NeumeisterDepartment of Psychiatry, New York University School of Medicine, New York.
Yale University · USCohen Children's Medical Center · USNew York University · USUnited States Department of Veterans Affairs · USUniversity of California San Diego · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
CB1 Receptor PET Imaging Reveals Gender Differencesin PTSDR01MH096876 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NEUMEISTER, ALEXANDER · 2012 to 2014
$921k
Kappa Opioid Receptor Imaging in PTSDR21MH096105 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NEUMEISTER, ALEXANDER · 2012 to 2014
$746k
KOR DepressionR01MH102566 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NEUMEISTER, ALEXANDER · 2014 to 2014
$438k
Serotonin 1B Receptor Imaging in PTSD with and without Co-morbid DepressionR21MH085627 · NIMH · YALE UNIVERSITY · PI NEUMEISTER, ALEXANDER · 2009 to 2010
$411k
NCRR NIH HHS UL1 RR024139NIMH NIH HHS R01MH096876NIMH NIH HHS R01MH102566NIMH NIH HHS R21MH085627NIMH NIH HHS R21MH096105
6 · The paper itself

Abstract

importanceExposure to trauma increases the risk for developing threat (ie, fear) symptoms, such as reexperiencing and hyperarousal symptoms, and loss (ie, dysphoria) symptoms, such as emotional numbing and depressive symptoms. While preclinical data have implicated the activated dynorphin/κ-opioid receptor (KOR) system in relation to these symptoms, the role of the KOR system in mediating these phenotypes in humans is unknown. Elucidation of molecular targets implicated in threat and loss symptoms is important because it can help inform the development of novel, mechanism-based treatments for trauma-related psychopathology.

objectiveTo use the newly developed [11C]LY2795050 radiotracer and high-resolution positron emission tomography to evaluate the relation between in vivo KOR availability in an amygdala-anterior cingulate cortex-ventral striatal neural circuit and the severity of threat and loss symptoms. We additionally evaluated the role of 24-hour urinary cortisol levels in mediating this association. DESIGN, SETTING, AND

participantsThis cross-sectional positron emission tomography study under resting conditions was conducted at an academic medical center. Thirty-five individuals representing a broad transdiagnostic and dimensional spectrum of trauma-related psychopathology, ranging from nontrauma-exposed psychiatrically healthy adults to trauma-exposed adults with severe trauma-related psychopathology (ie, posttraumatic stress disorder, major depressive disorder, and/or generalized anxiety disorder). MAIN OUTCOMES AND MEASURES: [11C]LY2795050 volume of distribution values in amygdala-anterior cingulate cortex-ventral striatal neural circuit; composite measures of threat (ie, reexperiencing, avoidance, and hyperarousal symptoms) and loss (ie, emotional numbing, major depressive disorder, and generalized anxiety disorder symptoms) symptoms as assessed using the Clinician-Administered PTSD Scale, Hamilton Depression Rating Scale, and Hamilton Rating Scale for Anxiety; and 24-hour urinary cortisol levels.

results[11C]LY2795050 volume of distribution values in an amygdala-anterior cingulate cortex-ventral striatal neural circuit were negatively associated with severity of loss (r = -0.39; 95% CI, -0.08 to -0.66), but not threat (r = -0.03; 95% CI, -0.30 to 0.27), symptoms; this association was most pronounced for dysphoria symptoms (r = -0.45; 95% CI, -0.10 to -0.70). Path analysis revealed that lower [11C]LY2795050 volume of distribution values in this circuit was directly associated with greater severity of loss symptoms and indirectly mediated by 24-hour urinary cortisol levels. CONCLUSIONS AND RELEVANCE: Results of this study suggest that KOR availability in an amygdala-anterior cingulate cortex-ventral striatal neural circuit mediates the phenotypic expression of trauma-related loss (ie, dysphoria) symptoms. They further suggest that an activated corticotropin-releasing factor/hypothalamic-pituitary-adrenal axis system, as assessed by 24-hour urinary cortisol levels, may indirectly mediate this association. These results may help inform the development of more targeted, mechanism-based transdiagnostic treatments for loss (ie, dysphoric) symptoms.

Indexed as

AdultAmygdalaBenzamidesCarbon RadioisotopesCase-Control StudiesCross-Sectional StudiesDepressionFemaleFunctional NeuroimagingGyrus CinguliHumansHydrocortisoneMaleNeural PathwaysPhobic DisordersPositron-Emission Tomography3-chloro-4-(4-((2-(3-pyridyl)pyrrolidin-1-yl)methyl)phenoxy)benzamideBenzamidesCarbon RadioisotopesHydrocortisonePyrrolidinesReceptors, Opioid, kappa

Identifiers

PMID25229257
OpenAlexW1971522057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.